High photothermal conversion efficiency of RF sputtered TiO Magneli phase thin films and its linear correlation with light absorption capacity.

RF-sputtering is used to deposit TiO-Magneli-phase films onto various substrates at deposition temperatures (T) ranging from 25 to 650 °C. Not only the structural, but also electrical conductivity, optical absorbance and photothermal properties of the TiO films are shown to change significantly with T. A T of 500 °C is pointed out as the optimal temperature that yields highly-crystalized pure-TiO-Magneli phase with a densely-packed morphology and a conductivity as high as 740 S/cm.

Classic biphasic pulmonary blastoma with endobronchial invasion in a 16-year-old male: A rare case report.

Pulmonary blastoma (PB) is a rare and aggressive lung neoplasm, representing 0.25 %-0.50 % of lung cancers and characterized by biphasic histology with both epithelial and mesenchymal components.

Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer's Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling.

Alzheimer's disease (AD) is the most common neurodegenerative disorder in the world. Due to failure of the traditional drugs to produce a complete cure for AD, the search for new safe and effective lines of therapy has attracted the attention of ongoing research. Canagliflozin is an anti-diabetic agent with proven efficacy in the treatment of neurological disorders in which mitochondrial dysfunction, oxidative stress, apoptosis, and autophagy play a pathophysiological role.

Targeting the Sirtuin-1/PPAR-Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson's Disease.

Parkinson's disease (PD) is a pathological state characterized by a combined set of abnormal movements including slow motion, resting tremors, profound stiffness of skeletal muscles, or obvious abnormalities in posture and gait, together with significant behavioral changes. Until now, no single therapeutic modality was able to provide a complete cure for PD. This work was a trial to assess the immunomodulatory effects of canagliflozin with or without levodopa/carbidopa on rotenone-induced parkinsonism in Balb/c mice.